Nicotine Replacement Therapy and Smoking Cessation Medication Postal Supply within Suffolk
key details
| Value | £400,000 (£480,000 inc. VAT) |
|---|---|
| Status | planning |
| Category (CPV) | 33600000 +2 more |
| Region | East of England |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-06d39c |
description
Suffolk County Council (Public Health, Communities and Public Safety) is undertaking a soft market testing questionnaire to inform a potential future procurement for the postal supply of Nicotine Replacement Therapy (NRT) and smoking cessation prescription medication.
Smoking prevalence in Suffolk is currently estimated at 10.5%. The Council's ambition is to reduce this to 5% or below by 2030. NRT and prescribed smoking cessation medications are recognised as effective interventions to support people to quit smoking and remain an important element of the local stop smoking offer. The Council currently provides access to these products through a pharmacy-based pathway. However, not all clients are able to access participating pharmacies due to factors such as working hours, limited transport options or mobility issues. The Council is therefore exploring alternative delivery models to improve accessibility.
The Council is considering a procurement comprising two lots. Suppliers may bid for either lot individually or for both lots.
Lot 1 - Nicotine Replacement Therapy (NRT)
Supply a range of NRT products following referral from the Council's commissioned stop smoking service (FGS) and deliver products directly to clients using a reliable and secure postal service.
Lot 2 - Smoking cessation prescription medication
Undertake remote clinical consultations with clients referred by the stop smoking service to assess suitability for Varenicline or Cytisine and, where clinically appropriate, supply medication directly to clients using a reliable and secure postal service.
This exercise is exploratory and non-evaluative. It is intended to inform the Council's understanding of market capability, potential delivery models, implementation timescales and indicative costs. The anticipated contract value is approximately £400,000 (approximately £100,000 per annum) for an initial two-year contract with the option to extend for up to a further two years.
This notice does not constitute a call for competition or a commitment to procure.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 24 Jul 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 070447-2026 |
more from Suffolk County Council
- Feel Good Suffolk AI and Digital Offer Development · £169,500 · 27 Jul 2026
- Recruitment of up to 13 FTE Locum Social Workers · £0 · 22 Jul 2026
- Toxicology Service for HM Coroner for Suffolk · 21 Jul 2026
- Insurance Services · £6,627,500 · 9 Jul 2026
- Supported Housing Development · 29 Jun 2026
- Provision of Suffolk Adult Learning Service · 24 Jun 2026
- Consultancy Services Transport East · 19 Jun 2026
- Dual placement (2-bed) residential children's home for Suffolk children in care aged 12-17 years including those aged 17 years · £3,500,000 · 11 Jun 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.